Jayme L. Fletcher

Jayme L. Fletcher serves as a key procurement professional within the Naval Medical Logistics Command (N62645), supporting the Department of Defense’s mission to sustain combat-ready medical forces through the acquisition of critical diagnostic, surgical, and life-sustaining equipment. Responsible for managing complex contracting actions across global operational theaters, Fletcher specializes in securing advanced medical technologies that enable point-of-care diagnostics, battlefield trauma care, and preventive medicine capabilities. Their work directly supports the Navy and Marine Corps’ readiness posture by ensuring timely delivery of mission-critical medical assets under stringent operational and regulatory standards. Fletcher’s contracting portfolio is characterized by a strong emphasis on commercial-off-the-shelf (COTS) and modified commercial medical devices, with relationships spanning established defense contractors and specialized medical technology firms. While no single vendor dominates the award profile, the procurement approach favors competitive, open-market solicitations under FAR Part 15, with a preference for firms possessing ISO 13485 certification and FDA regulatory compliance. Contracting patterns reflect a focus on long-term sustainment and technical support, often incorporating performance-based service contracts and maintenance clauses to ensure equipment reliability in austere environments. Set-aside preferences are overwhelmingly non-set-aside, with 96.8% of awards issued under full and open competition. Small business participation is minimal but intentional, with 1.6% of awards directed to 8(a) firms and another 1.6% to total small business set-asides under FAR 19.5, indicating a compliance-driven rather than aggressively targeted socioeconomic strategy. Fletcher’s primary NAICS focus includes surgical and medical instrument manufacturing (339112), electromedical apparatus production (334510), and biotechnology R&D (541714), reflecting deep expertise in procuring diagnostic imaging systems, portable electrotherapeutic devices, and next-generation biometric monitoring tools. This technical alignment underscores a specialized domain knowledge in clinical engineering and battlefield medical innovation.